Warfarin and Exenatide: Interaction Details

Brand names
Exenatide
BydureonByetta
Warfarin
CoumadinJantoven
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Exenatide

Brand names
  • Bydureon
  • Byetta

We don't have a drug information page for Exenatide yet. Have a question about Exenatide? Ask a pharmacist, free →

Warfarin

Brand names
  • Coumadin
  • Jantoven

What Happens When You Take Warfarin With Exenatide

What can happen when they are taken together (rated Moderate)

An increased risk of bleeding and an increase in

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Postmarketing reports describe elevated INR, occasionally accompanied by bleeding, when exenatide was used together with warfarin. In a study, giving warfarin 35 minutes after repeated exenatide doses pushed warfarin Tmax back by roughly 2 hours, but , , and INR showed no clinically relevant differences.1

An open-label study in healthy male participants found that giving exenatide and warfarin together had no clinically significant effect on the pharmacokinetics or of warfarin.3 A small retrospective cohort study of warfarin-treated patients also found that adding a GLP-1 receptor (GLP1-RA, exenatide among them) did not meaningfully change the time in therapeutic INR range, comparing the 90 days after GLP1-RA initiation with the 90 days before.2

For patients on warfarin, prothrombin time (PT) should be checked more often once exenatide is started or its regimen changed. After a stable PT has been documented, monitoring can return to the interval normally advised for warfarin-treated patients.1

The Warfarin and Exenatide Interaction, Explained

Exenatide may slightly raise the effect of warfarin in some people. Exenatide slows how fast your stomach empties, which may change how quickly warfarin is absorbed. There have been reports of a higher (a blood test showing how long your blood takes to clot), sometimes with bleeding. Still, studies in healthy people and in patients did not show a meaningful change in warfarin's effect for most.

Watch for unusual bruising, nosebleeds, bleeding gums, or black stools. Keep taking both as prescribed. Your care team can manage this by checking your INR more often when exenatide is started or changed.

Mechanism: exenatide (GLP-1 receptor ) delays gastric emptying, which may alter warfarin . Warfarin is a drug, so small changes in exposure can matter.

  • Effect: postmarketing reports of increased , sometimes with bleeding.
  • Data: in a PK study warfarin Tmax was delayed about 2 hours with no clinically relevant change in , , or INR. An open-label study in healthy males and a small retrospective cohort (time in unchanged) showed no significant effect.
  • Onset: unspecified. Evidence: probable. Severity: moderate.
  • Management: monitor PT/INR more frequently after initiation or dose change of exenatide. Once stable, resume usual monitoring intervals.

See the 3 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Warfarin and Exenatide Interact

The likely mechanism

Delayed gastric emptying by exenatide resulting in increased warfarin

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Warfarin and Exenatide Interaction

Keep taking both medicines as prescribed. Do not change or stop either one on your own.

  • Your care team may check your (PT) blood test more often when exenatide is started or its dose is changed.
  • Once your results are stable, testing can usually return to your normal schedule.
  • Your warfarin dose may need to be adjusted and individualized by your care team based on your results.
  • Tell your pharmacist or prescriber if you notice unusual bruising, bleeding, or dark stools, or if you start, stop, or change exenatide.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Warfarin or Exenatide need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

Literature Reports

3 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Warfarin and GLP-1 receptor agonist interaction effects on time in therapeutic range

    A small retrospective cohort study of patients taking warfarin (N=28) found that adding a GLP-1 receptor (GLP1-RA) did not significantly change time in therapeutic range (TTR) in the 90 days after GLP1-RA initiation relative to the 90 days before. Patients were excluded if either drug was stopped within 90 days of GLP1-RA initiation, or if fewer than 4 INR measurements were available in the 90 days before and after initiation.

    The mean age of participants was 59.4 years and 46% were male. Warfarin was most often prescribed for mechanical valves (n=9), then atrial fibrillation/flutter (n=7) and VTE (n=7); 5 patients took warfarin for other indications.

    At baseline, 79% (n=22) had a diagnosis of diabetes. Semaglutide was the most frequently prescribed GLP1-RA (n=10), followed by exenatide (n=8), dulaglutide (n=5), liraglutide (n=4), and tirzepatide (n=1).

    Average TTR was 59% before and 60% after GLP1-RA initiation, and the percentage of in-range INR values was 56.6% before and 51.9% after initiation. No patient had bleeding after starting a GLP1-RA. Among a subgroup with a baseline TTR of 80% or higher, TTR fell to 70% after GLP1-RA initiation.2

  2. Report 2 · Study title

    Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men

    In an open-label, 2-period, fixed-sequence study, giving warfarin together with exenatide had no clinically significant effect on the or of warfarin. Healthy male subjects (n=25) took a single oral 25-mg dose of warfarin in period 1.

    In period 2, which began 1 week later, exenatide was given subcutaneously for 4 days (5 mcg twice daily for 2 days, then 10 mcg twice daily for 2 days). On day 4, a second oral 25-mg warfarin dose was administered within 35 minutes of the exenatide dose, and exenatide 10 mcg twice daily was continued for 5 more days.

    Mean -time profiles of both R- and S-warfarin were not significantly changed. The least squares (LS) geometric mean ratios of (warfarin plus exenatide/warfarin in all cases) were 1.11 (90% confidence interval (CI), 1.06 to 1.17) for R-warfarin and 1.06 (90% CI, 1.01 to 1.11) for S-warfarin.

    The LS geometric mean ratios of were 1.05 (90% CI, 1 to 1.09) for R-warfarin and 0.97 (90% CI, 0.93 to 1.01) for S-warfarin. Warfarin Tmax was, however, delayed, with median increases of 1 hour for R-warfarin and 2 hours for S-warfarin.

    Maximal values were similar in the two periods, with an LS geometric mean ratio of 0.94 (90% CI, 0.93 to 0.96). No abnormal bleeding episodes occurred during the study. This interaction was not thought to be related to , and its exact mechanism is unknown.3

  3. Report 3 · Study title

    Prescribing information: BYETTA subcutaneous injection, exenatide subcutaneous injection

    Postmarketing reports for exenatide describe increased with warfarin use, at times accompanied by bleeding. In healthy volunteers, giving warfarin (25 mg) 35 minutes after repeated exenatide doses (5 mcg twice daily on Days 1 and 2, then 10 mcg twice daily on Days 3 through 9) delayed warfarin Tmax by about 2 hours.

    No clinically relevant effects were seen on the or of the S- and R-enantiomers of warfarin. Exenatide did not significantly change the properties (eg, INR) of warfarin.1

Warfarin and Exenatide: Common Questions

How serious is the Warfarin and Exenatide interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How is the Warfarin and Exenatide interaction managed?

Keep taking both medicines as prescribed. Do not change or stop either one on your own. Your care team may check your (PT) blood test more often when exenatide is started or its dose is changed. Once your results are stable, testing can usually return to your normal schedule. Your warfarin dose may need to be adjusted and individualized by your care team based on your results. Tell your pharma… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Warfarin and Exenatide Interaction

Ask in your own words about taking Warfarin and Exenatide together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (3)

  1. Product Information: BYETTA(R) subcutaneous injection, exenatide subcutaneous injection. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2025. DailyMed
  2. Anjum P, Akbashev M, Utz A, et al: Warfarin and GLP-1 receptor agonist interaction effects on time in therapeutic range. Blood 2024; 144(Suppl 1):5579. DOI
  3. Soon D, Kothare PA, Linnebjerg H, et al: Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men. J Clin Pharmacol 2006; 46(10):1179-1187. PubMed
Was this write-up helpful?

Other Serious Interactions of Warfarin and Exenatide

Also serious with Exenatide

Also serious with Warfarin

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Exenatide

With Warfarin

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring. This interaction.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.